Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Levetiracetam
- Therapeutic area
- CNS & mental health
- Drug class
- Antiepileptics
- ATC
- N03
- Strength
- 100 mg/mL
- Dosage form
- Oral solution
- Pack
- 120ml
- Registration no.
- 116614
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-11 02:59
Manufacturer
Global Pharmaceuticals (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Eppra (Levetiracetam) is used for
Levetiracetam is an antiseizure (antiepileptic) medicine. It helps stop epileptic seizures (fits) by calming the signals in the brain that can set them off. It is a prescription medicine. It comes as tablets, a liquid, granules and tablets that dissolve on the tongue, and in hospital it can also be given into a vein when someone cannot take it by mouth. It controls epilepsy but does not cure it, so it is usually taken long term.
- Focal (partial-onset) seizures, which start in one part of the brain and may spread. It can be used on its own in teenagers and adults with newly diagnosed epilepsy.
- Focal seizures in babies, children and adults, added to other epilepsy medicines
- Myoclonic seizures (sudden brief jerks) in juvenile myoclonic epilepsy, added to other epilepsy medicines
- Primary generalised tonic-clonic seizures (where the whole body stiffens and jerks), added to other epilepsy medicines
- Given into a vein in hospital for a short time when the tablets or liquid cannot be taken
Get medical help straight away if
- Call an ambulance or go to the emergency department for signs of a severe allergic reaction: swelling of the face, lips, tongue or throat, trouble breathing, or feeling faint or dizzy.
- Get emergency help for a serious skin reaction: a spreading rash with blisters or peeling skin, or target-shaped spots on the skin.
- Get urgent help straight away for any thoughts of harming yourself or ending your life. Family and carers should watch for these signs too.
- Get medical help straight away for a rash with fever, swollen glands and flu-like feelings, as this can be a sign of a reaction affecting the organs (DRESS).
Side effects, warnings and interactions for Levetiracetam
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Levetiracetam
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Levetiracetam is right for you and the dose.
- Epilepsy: first choice for focal seizures, and for generalised tonic-clonic seizures in girls and women who may become pregnant
About Eppra 100 mg/mL oral solution
Eppra 100 mg/mL oral solution contains Levetiracetam 100 mg/mL. It is registered with DRAP by Global Pharmaceuticals (Pvt.) Ltd (registration no. 116614). Its official price is PKR 1,775.51 for a pack of 120ml. This price has applied since 27 July 2026. It is sold in 2 pack sizes: 60ml and 120ml. Eppra is also available as 500 mg extended-release tablet, 500 mg/5 mL injection, 250 mg tablet and 500 mg tablet. 28 other brands of Levetiracetam 100 mg/mL (oral solution) are registered in Pakistan. Compare all brands and prices →
Eppra 100 mg/mL pack sizes and prices
| Pack | Official price | Per tablet |
|---|---|---|
| 60ml | PKR 887.76 | — |
| 120ml (this page) | PKR 1,775.51 | — |
Other strengths of Eppra
All 28 other brands of Levetiracetam 100 mg/mL solution in Pakistan
These 28 brands are alternatives (substitutes) to Eppra: each contains Levetiracetam 100 mg/mL solution. Ask your doctor or pharmacist before you switch brands.
Sorted by price per mL, lowest first. The lowest is Livilip (Winthrox Laboratories Pvt. Ltd) at PKR 8.30 per mL; the highest is Lekra at PKR 16.77. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Livilip | Winthrox Laboratories Pvt. Ltd | 10ml | PKR 82.95 | PKR 8.30 / mL |
| Levelanz | Abbott Laboratories (Pakistan) Limited | 120ml | PKR 1,100.67 | PKR 9.17 / mL |
| LEVELANZ ORAL | Abbott Laboratories (Pakistan) Limited | 30ml | PKR 290.46 | PKR 9.68 / mL |
| Orgatam | Semos Pharmaceuticals PVT LTD | 60ml | PKR 584.85 | PKR 9.75 / mL |
| Tamlev | Medisure Laboratories Pakistan Pvt Ltd | 30ml | PKR 317.32 | PKR 10.58 / mL |
| Tricetam Oral | Mediate Pharmaceutical Pvt Ltd | 30ml | PKR 329.30 | PKR 10.98 / mL |
| Tricetam | Mediate Pharmaceutical Pvt Ltd | 15ml | PKR 173.31 | PKR 11.55 / mL |
| Barlev | Barrett Hodgson Pakistan (Pvt.) Ltd | 60ml | PKR 707.64 | PKR 11.79 / mL |
| Levixa | HIGH-Q Pharmaceuticals | 10ml | PKR 132.04 | PKR 13.20 / mL |
| Lectom Oral | Focus & Rulz Pharmaceuticals (Pvt) Ltd | 30 ml | PKR 400.13 | PKR 13.34 / mL |
| Lovitrim | Davis Pharmaceutical Laboratories | 10ml | PKR 133.83 | PKR 13.38 / mL |
| Recetam | M/s. Genix Pharma (Pvt) Ltd | 60ml | PKR 813.79 | PKR 13.56 / mL |
| Tericim | Medisave Pharmaceuticals | 30ml | PKR 409.28 | PKR 13.64 / mL |
| Levace | Seraph Pharmaceutical | 30ml | PKR 416.53 | PKR 13.88 / mL |
| Lectom | Focus & Rulz Pharmaceuticals (Pvt) Ltd | 15ml | PKR 210.59 | PKR 14.04 / mL |
| Xeticam | Getz Pharma (Pvt) Limited | 30ml | PKR 429.50 | PKR 14.32 / mL |
| Eplipsa | Helix Pharma (Pvt)., Ltd | 30ml | PKR 429.50 | PKR 14.32 / mL |
| Seitam | Glitz Pharma | 10 ml | PKR 143.20 | PKR 14.32 / mL |
| Lecetam | Indus Pharma (Pvt.) Ltd | 10ml | PKR 144.82 | PKR 14.48 / mL |
| LERACE | Hilton Pharma (Pvt) Limited | 10ml | PKR 145.46 | PKR 14.55 / mL |
Show all 28 brands
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| LEVOTAM | Platinum Pharmaceuticals | 60ml | PKR 887.62 | PKR 14.79 / mL |
| Lepsi | Genetics Pharmaceuticals Pvt. Ltd | 120ml | PKR 1,775.43 | PKR 14.80 / mL |
| Levra | Standpharm Pakistan Pvt Ltd | 60ml | PKR 887.74 | PKR 14.80 / mL |
| Lumark | The Searle Company Limited | 60 ml | PKR 887.74 | PKR 14.80 / mL |
| Vetrawin | Amarant Pharmaceuticals Private Limited | 30ml | PKR 468.52 | PKR 15.62 / mL |
| Levelanz Oral | Pharmatec Pakistan (Pvt.) Limited | 30ml | PKR 468.53 | PKR 15.62 / mL |
| Elicia | Martin Dow Limited | 10ml | PKR 167.67 | PKR 16.77 / mL |
| Lekra | Hiranis Pharmaceuticals Pvt. Ltd | 10ml | PKR 167.68 | PKR 16.77 / mL |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Eppra, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Global Pharmaceuticals (Pvt.) Ltd., Islamabad
- DRAP registration
- 116614
- Phone
- +92 336 5559068
- info@globalpharmaceuticalspk.com
- Website
- https://www.globalpharmaceuticalspk.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 23 October 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (120ml). Current price PKR 1,775.51, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Eppra 100 mg/mL, 120ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/eppra-100-mg-ml-116614-60ml-global-pharmaceuticals-pvt-ltd/ (accessed 12 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,775.51 | 2026-07-27 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 116614Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.